|
Coumarins
Citations 11-20 of 69 total displayed.
|
Past content
(since Oct 2001):
|
- Original Contributions
The Challenge of Designing a Treatment Trial for Warfarin-Associated Intracerebral Hemorrhage
- Matthew L. Flaherty, Opeolu Adeoye, Padmini Sekar, Mary Haverbusch, Charles J. Moomaw, Haiyang Tao, Joseph P. Broderick, and Daniel Woo
Stroke 2009;40:1738-1742; published online before print as doi:10.1161/STROKEAHA.108.538462
[Abstract]
[Full text]
- Original Contributions
Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators
- Carl van Walraven, Robert G. Hart, Stuart Connolly, Peter C. Austin, Jonathan Mant, F.D. Richard Hobbs, Peter J. Koudstaal, Palle Petersen, Francisco Perez-Gomez, J. Andre Knottnerus, Beppie Boode, Michael D. Ezekowitz, and Daniel E. Singer
Stroke 2009;40:1410-1416; published online before print as doi:10.1161/STROKEAHA.108.526988
[Abstract]
[Full text]
- Articles
The Challenge of Designing a Treatment Trial for Warfarin-Associated Intracerebral Hemorrhage
- Matthew L. Flaherty, Opeolu Adeoye, Padmini Sekar, Mary Haverbusch, Charles J. Moomaw, Haiyang Tao, Joseph P. Broderick, and Daniel Woo
Stroke published March 12, 2009, doi:10.1161/STROKEAHA.108.538462
[Abstract]
- Original Contributions
Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
- Tanya N. Turan, Lucian Maidan, George Cotsonis, Michael J. Lynn, Jose G. Romano, Steven R. Levine, Marc I. Chimowitz for the WASID Investigators
Stroke 2009;40:505-509; published online before print as doi:10.1161/STROKEAHA.108.528281
[Abstract]
[Full text]
- Articles
Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation. The Atrial Fibrillation Investigators
- Carl van Walraven, Robert G. Hart, Stuart Connolly, Peter C. Austin, Jonathan Mant, F. D. Richard Hobbs, Peter J. Koudstaal, Palle Petersen, Francisco Perez-Gomez, J. Andre Knottnerus, Beppie Boode, Michael D. Ezekowitz, and Daniel E. Singer
Stroke published January 29, 2009, doi:10.1161/STROKEAHA.108.526988
[Abstract]
- Articles
Failure of Antithrombotic Therapy and Risk of Stroke in Patients With Symptomatic Intracranial Stenosis
- Tanya N. Turan, Lucian Maidan, George Cotsonis, Michael J. Lynn, Jose G. Romano, Steven R. Levine, Marc I. Chimowitz for the WASID Investigators
Stroke published December 18, 2008, doi:10.1161/STROKEAHA.108.528281
[Abstract]
- Original Contributions
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? • Supplemental Appendix
- Mark H. Eckman, Lawrence K.S. Wong, Yannie O.Y. Soo, Wynnie Lam, Song Ran Yang, Steven M. Greenberg, and Jonathan Rosand
Stroke 2008;39:3308-3315; published online before print as doi:10.1161/STROKEAHA.108.523159
[Abstract]
[Full text]
- Original Contributions
Experimental Model of Warfarin-Associated Intracerebral Hemorrhage
- Christian Foerch, Ken Arai, Guang Jin, Kyung-Pil Park, Stefanie Pallast, Klaus van Leyen, and Eng H. Lo
Stroke 2008;39:3397-3404; published online before print as doi:10.1161/STROKEAHA.108.517482
[Abstract]
[Full text]
- Original Contributions
Hematoma Growth in Oral Anticoagulant Related Intracerebral Hemorrhage
- Brett Cucchiara, Steven Messe, Lauren Sansing, Scott Kasner, Patrick Lyden for the CHANT Investigators
Stroke 2008;39:2993-2996; published online before print as doi:10.1161/STROKEAHA.108.520668
[Abstract]
[Full text]
- Original Contributions
Disparate Stroke Rates on Warfarin Among Contemporaneous Cohorts With Atrial Fibrillation: Potential Insights Into Risk From a Comparative Analysis of SPORTIF III Versus SPORTIF V
- Elaine M. Hylek, Lars Frison, Lori E. Henault, and Adrienne Cupples
Stroke 2008;39:3009-3014; published online before print as doi:10.1161/STROKEAHA.108.514935
[Abstract]
[Full text]
|
|
